Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Tangible Net Worth Ratio
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Tangible Net Worth Ratio of 79.4% as of September 2025. This metric is calculated by deducting intangible assets (CN¥848.75 Million) from net assets (CN¥4.13 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 002317 total equity for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Guangdong Zhongsheng Pharmaceutical Co Ltd Tangible Net Worth Ratio (2006–2024)
This chart shows how Guangdong Zhongsheng Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 19 annual periods from 2006 to 2024. As of September 2025, the ratio stands at 79.4%, reflecting net assets of CN¥4.13 Billion with intangible assets of CN¥848.75 Million CNY. Also explore 002317 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Guangdong Zhongsheng Pharmaceutical Co L worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 79.9% | CN¥4.01 Billion | CN¥807.41 Million | CN¥5.55 Billion | ▼ -10.3 pp |
| 2023 | 90.1% | CN¥4.53 Billion | CN¥446.70 Million | CN¥6.46 Billion | ▲ +11.3 pp |
| 2022 | 78.8% | CN¥3.82 Billion | CN¥808.83 Million | CN¥5.78 Billion | ▼ -3.1 pp |
| 2021 | 81.9% | CN¥3.54 Billion | CN¥641.15 Million | CN¥4.90 Billion | ▼ -2.0 pp |
| 2020 | 83.9% | CN¥3.63 Billion | CN¥583.52 Million | CN¥4.78 Billion | ▼ -1.7 pp |
| 2019 | 85.6% | CN¥4.13 Billion | CN¥596.47 Million | CN¥5.51 Billion | ▲ +0.6 pp |
| 2018 | 84.9% | CN¥3.95 Billion | CN¥595.60 Million | CN¥5.24 Billion | ▼ -2.9 pp |
| 2017 | 87.9% | CN¥3.73 Billion | CN¥452.37 Million | CN¥4.86 Billion | ▼ -0.1 pp |
| 2016 | 88.0% | CN¥3.42 Billion | CN¥412.14 Million | CN¥4.23 Billion | ▲ +5.4 pp |
| 2015 | 82.6% | CN¥2.11 Billion | CN¥366.79 Million | CN¥3.33 Billion | ▼ -8.8 pp |
| 2014 | 91.4% | CN¥1.90 Billion | CN¥163.22 Million | CN¥2.31 Billion | ▼ -4.2 pp |
| 2013 | 95.6% | CN¥1.74 Billion | CN¥76.51 Million | CN¥1.98 Billion | ▼ -1.2 pp |
| 2012 | 96.8% | CN¥1.59 Billion | CN¥50.84 Million | CN¥1.74 Billion | ▲ +0.3 pp |
| 2011 | 96.4% | CN¥1.48 Billion | CN¥52.47 Million | CN¥1.57 Billion | ▼ -1.3 pp |
| 2010 | 97.7% | CN¥1.39 Billion | CN¥31.72 Million | CN¥1.48 Billion | ▲ +0.2 pp |
| 2009 | 97.5% | CN¥1.30 Billion | CN¥32.06 Million | CN¥1.40 Billion | ▲ +16.6 pp |
| 2008 | 80.9% | CN¥172.40 Million | CN¥32.85 Million | CN¥314.92 Million | ▲ +4.9 pp |
| 2007 | 76.0% | CN¥130.56 Million | CN¥31.32 Million | CN¥297.74 Million | ▼ -0.9 pp |
| 2006 | 76.9% | CN¥138.72 Million | CN¥32.00 Million | CN¥291.65 Million | — |